Log in to save to my catalogue

Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia

Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11334575

Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia

About this item

Full title

Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia

Publisher

New York: Springer US

Journal title

Journal of neuroimmune pharmacology, 2022-12, Vol.17 (3-4), p.487-502

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

HIV-Associated Dementia (HAD) is a significant comorbidity that many HIV-patients face. Our study utilized QIAGEN Ingenuity Pathway Analysis (IPA) to identify and analyze molecular profiles and pathways underlying nicotine’s impact on HAD pathology. The Qiagen Knowledge Base (QKB) defines HAD as “Dementia associated with acquired immunodeficiency s...

Alternative Titles

Full title

Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11334575

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11334575

Other Identifiers

ISSN

1557-1890,1557-1904

E-ISSN

1557-1904

DOI

10.1007/s11481-021-10027-2

How to access this item